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Caspase-generated fragment of the Met receptor
favors apoptosis via the intrinsic pathway
independently of its tyrosine kinase activity
J Lefebvre1, G Muharram1, C Leroy1, Z Kherrouche1, R Montagne1, G Ichim2, S Tauszig-Delamasure2, A Chotteau-Lelievre1,
C Brenner3, P Mehlen2 and D Tulasne*,1
The receptor tyrosine kinase Met and its ligand, the hepatocyte growth factor, are essential to embryonic development, whereas
the deregulation of Met signaling is associated with tumorigenesis. While ligand-activated Met promotes survival, caspase-
dependent generation of the p40 Met fragment leads to apoptosis induction – hallmark of the dependence receptor. Although the
survival signaling pathways induced by Met are well described, the pro-apoptotic signaling pathways are unknown. We show
that, although p40 Met contains the entire kinase domain, it accelerates apoptosis independently of kinase activity. In cell
cultures undergoing apoptosis, the fragment shows a mitochondrial localization, required for p40 Met-induced cell death.
Fulminant hepatic failure induced in mice leads to the generation of p40 Met localized also in the mitochondria, demonstrating
caspase cleavage of Met in vivo. According to its localization, the fragment induces mitochondrial permeabilization, which is
inhibited by Bak silencing and Bcl-xL overexpression. Moreover, Met silencing delays mitochondrial permeabilization induced
by an apoptotic treatment. Thus, the Met-dependence receptor in addition to its well-known role in survival signaling mediated by
its kinase activity, also participates in the intrinsic apoptosis pathway through the generation of p40 Met – a caspase-dependent
fragment of Met implicated in the mitochondrial permeabilization process.
Cell Death and Disease (2013) 4, e871; doi:10.1038/cddis.2013.377; published online 17 October 2013
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Dependence receptors are bifunctional receptors that are able
to mediate both efficient cell survival after ligand binding and
apoptotic cell death in the absence of the ligand. To date,415
dependence receptors have been identified, belonging to
several membrane receptor families: single-pass type I
receptors, receptor tyrosine kinases (RTK), integrins and
multipass membrane proteins. For most dependence recep-
tors, the cytoplasmic or membrane-anchored fragments
generated by caspase cleavages are direct inducers of
apoptosis.1
The RTK Met is classified as a dependence receptor
because it strongly induces cell survival in the presence of
ligand and favors apoptosis when cleaved by caspase.2
Met, expressed predominantly at the surface of epithelial
cells, is activated by its ligand – the hepatocyte growth factor/
scatter factor (HGF/SF). Ligand-activated Met stimulates
proliferation, scattering, invasion and morphogenesis, and
protects a number of cell types against apoptosis.3 The Met
receptor and its ligand are essential to embryonic develop-
ment, as mouse mutants affected in either ligand or receptor
show defects in placenta, liver, muscle and neuron
formation.4–6 The size reduction of the liver in these mice
results from massive apoptosis, highlighting the involvement
of HGF/SF-Met signaling in hepatocyte survival.5
The PI3K-Akt and RAS-ERK signaling pathways have a
central role in the anti-apoptotic responses induced by
activated Met.2 The apoptotic process is notably regulated
by proteins of the Bcl-2 family, whose action affects the
intrinsic apoptosis pathway involving mitochondrial outer
membrane permeabilization (MOMP). In many studies,
HGF/SF-induced survival responses have been found to
correlate with increased expression of the anti-apoptotic
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Bcl-xL and Bcl-2 proteins, which inhibit mitochondria-depen-
dent apoptosis.7,8 Upon HGF/SF stimulation, furthermore, Akt
phosphorylates the pro-apoptotic BH3-only protein Bad,
causing its inactivation and thereby preventing apoptosis.9
In addition to the well-known involvement of ligand-
activated Met in cell survival, we previously demonstrated
that the Met receptor can directly favor apoptosis. Under
stress conditions, activated caspases can cleave Met within
the C-terminal DNID1374 motif and the juxtamembrane
ESVD1000 motif (mouse sequence),
10,11 thus generating an
intracellular 40-kDa fragment containing the kinase domain.
This p40 Met fragment can trigger apoptosis, and expression
of a caspase-uncleavable Met causes resistance to apoptosis.
In response to HGF/SF, induction of the survival signaling
pathway and phosphorylation of Met near the juxtamembrane
caspase site prevent the generation of p40 Met.12
Although the survival signaling pathways induced by
membrane receptors have been extensively studied, the
relevant pro-apoptotic signaling pathways have been
deciphered only recently. Caspase cleavages of DCC,
Patched and UNC5 release fragments containing addiction
or dependence domains (ADD) – that is, interacting domains
promoting recruitment of pro-apoptotic factors. These recruit-
ments lead to caspase activation – a mechanism reminiscent
of the extrinsic apoptosis pathway.13
The mechanisms by which tyrosine-kinase-family depen-
dence receptors promote apoptosis are unknown. We show
here that p40Met favors apoptosis independently of its kinase
activity but triggers mitochondrial permeabilization. Thus,
unlike previously described dependence receptors, Met
amplifies apoptosis via the intrinsic pathway.
Results
Expression of p40 Met amplifies epithelial cell apoptosis.
We have previously shown that during apoptosis, Met is
cleaved by caspases giving rise to a 40-kDa fragment10,11
(Figure 1a). For specific detection of p40 Met generation, we
developed an antibody against the neo-epitope created by
juxtamembrane cleavage. MCF-10A human mammary
epithelial cells were treated for an increasing period of time
with the apoptosis inducer staurosporin, and Met expression
was evaluated with an antibody against its kinase domain or
with the anti-p40 Met antibody. Whereas anti-Met kinase
recognized both full-length Met and p40 Met, the anti-p40
Met detected only a 40-kDa band during apoptosis
(Figure 1b). This 40-kDa band was indeed the Met fragment,
as a Met-targeting siRNA abolished its detection (Figure 1c).
The p40 Met fragment appeared 2 h after staurosporin
addition, simultaneously with the cleaved PARP, indicating
that p40 Met generation occurs early in the apoptotic
process.
We previously showed that p40 Met transient transfection
induces caspase-3 activation in about 15% of the transfected
cells.11 To further evaluate the involvement of p40 Met
expression, we generated Tet-on-inducible clones of MDCK
normal canine kidney epithelial cells expressing the mouse
Met fragment. Characterization of these inducible clones is
shown in Supplementary Figure S1. For the clone a, we
showed efficient detection of p40 Met with an anti-mouse Met
antibody that does not detect the endogenous Met
(Supplementary Figures S1A). Doxycycline was found to
induce p40 Met expression in a dose-dependent manner with
highest expression 12 h after induction (Supplementary
Figures S1B and C). As shown in Figure 2a, when apoptosis
was induced with TNF-a/cycloheximide, p40 Met expression
was found to accelerate cell death. Indeed, after 4 h of TNF-
CHX stimulation, the relative caspase activity was twice as
high in p40 Met-expressing cells as in control cells, whereas
no caspase activity increase was observed in the absence of
apoptosis induction (Figure 2b). This tallies with the level of
cell death, as evaluated by trypan blue staining (Figure 2c).
Acceleration of apoptosis was also observed by evaluation
PARP and caspase-3 cleavages after stimulation with TNF-
CHX (Figure 2d). By contrast, inducible expression of p40Met
did not induce caspase activation on its own. Increase in
PARP and caspase-3 cleavages were also observed after
treatment with another apoptosis inducer anisomycin
(Supplementary Figure S2A) and in a second p40 Met-
expressing clone (clone b) (Supplementary Figure S2B). By
contrast, wild-type MDCK cells (Supplementary Figure S2C)
and Tet-on inducible MDCK cells expressing a kinase-dead
p40 Met (p40 Met K1108A mutated at lysine 1108)
(Supplementary Figure S2D) displayed no increase. In later
time points of anisomycin treatment (10 and 12 h), inducible
p40 Met still increased cell death measured with trypan blue
staining, with higher level of cell death as expected. However,
at the end point of the time course (16 h), this increase is
attenuated, suggesting that cell death reached its maximal
level (Supplementary Figure S2E). It is noteworthy that in
transiently transfected cells, p40 Met can induce apoptosis on
its own. To checkwhether initial stress induced by transfection
can reveal p40 Met pro-apoptotic function, we transfected the
p40 Met Tet-on inducible cells with empty vector and induced
fragment expression. We show that doxycycline treatment or
transient transfection alone increased weakly or did not
increase apoptosis monitored with annexin V staining. By
contrast, transfected cells treated with doxycycline displayed
significant increase in annexin V staining (Supplementary
Figure S3), indicating that transfection-induced stress
induced p40 Met-dependent apoptosis. Thus, the p40 Met
fragment generated by caspase cleavage can accelerate
apoptotic cell death when overexpressed.
The p40 Met fragment is not an active kinase. We have
previously shown that the overexpression of p40 Met in
transiently transfected cells can lead to its tyrosine phospho-
rylation. Furthermore, mutation of lysine 1108 involved in
ATP binding abolished the apoptotic effects of p40 Met in
both transiently transfected cells and the inducible model.
We thus hypothesized that the p40 Met apoptotic effects
might depend on its kinase activity.10 Therefore, we first
determined its phosphorylation status, using antibodies
against the phosphorylated tyrosines. In contrast to transient
transfection experiments where p40 Met was phosphory-
lated, we failed to detect any phosphorylation of the fragment
in extracts of whole cells undergoing apoptosis or even in
fragment-enriched immunoprecipitates with the anti-p40 Met
antibody (Figure 3a). We obtained similar results in a time
course experiment (Supplementary Figure S4). In p40
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Met Tet-on inducible MDCK, likewise, we observed neither
p40 Met phosphorylation nor kinase activity (Figure 3b). By
contrast, the TPR-Met oncogene, a constitutively dimerized
form of Met, displayed proper phosphorylation and kinase
activity, whereas its kinase-dead version did not. Hence, the
p40 Met generated during apoptosis is not a constitutively
active kinase.
To test whether the action of p40 Met depends on its kinase
activity, we determined the effects of ATP mimetics targeting
selectively the Met kinase. Met inhibitor PHA-665752 failed to
inhibit the apoptosis induced by ectopically expressed p40
Met, as evaluated by caspase-3 cleavage (Figure 3c).
By contrast, such inhibitor prevented the HGF/SF-induced
survival, as evaluated by Met and PARP cleavage
(Supplementary Figure S5). In transformed cell lines
displaying constitutive Met activation, inhibition of its expres-
sion or kinase activity can lead to apoptosis.14,15 We checked,
in lung cancer cell lines EBC-1 displaying Met gene
amplification, whether the induction of cell death with Met
inhibitor can induce p40 Met generation. Indeed, the
treatment of EBC-1 with PHA-665752 was sufficient to induce
caspase-3 activation accompanied with decrease in Met and
generation of p40 Met fragment (Figure 3d). Taken together,
our results show that, although the survival response induced
by ligand-activated Met requires kinase activity, apoptosis
enhancement by p40 Met does not.
The subcellular localization of p40 Met governs its
pro-apoptotic action. To see how the localization of p40
Met might affect its pro-apoptotic action, we fused the 15AA
of the SRC myristoylation site, responsible for its membrane
anchorage, with p40 Met (SMS-p40 Met). Immuno-
fluorescence staining revealed both cytoplasmic and nuclear
p40 Met localization, whereas SMS-p40 Met was detected
Figure 1 Specific detection of p40 Met during apoptosis. (a) Schematic representation of p40 Met generated by caspase cleavage of the full-length Met receptor during
apoptosis. The neo-epitope produced by caspase cleavage of Met can be detected with a custom-made antibody. (b) MCF-10A epithelial cells were serum-starved overnight
and treated for the indicated times with staurosporin (Stauro; 1 mM). (c) MCF-10A were transfected for 24 h with a control siRNA (lanes 1 and 2) or a pool of three siRNAs
targeting Met, starved overnight and treated for 4 h with staurosporin. (b, c) For each condition, the same amount of proteins was resolved using 10% SDS-PAGE and
analyzed using western blotting with antibodies against the kinase domain of Met, against p40 Met, or against PARP. To assess loading an anti-b-actin or an anti-ERK2
antibody was used
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mainly at the plasma membrane (Figure 4a). Cell death,
evaluated by cleaved caspase-3 staining in MDCK cells,
appeared drastically reduced in SMS-p40 Met (Figure 4b).
p40 Met and SMS-p40 Met have been detected using
western blot at the expected size (Figure 4c). Thus, restoring
the membrane localization of the Met kinase domain inhibits
its pro-apoptotic action.
Mitochondrial localization of p40 Met. In subcellular
fractionation experiments, p40 Met generated in stauro-
sporin-treated MCF-10A cells was found in both the nuclear
and mitochondrial fractions (Figure 5a). The effectiveness of
purification was attested by the enrichment of Cox IV in
the mitochondrial, Nuc p62 in nuclear and GAPDH in
cytoplasmic fractions, respectively.
To assess the presence of p40 Met fragment in vivo, we
examined its generation in the mouse treated with anti-Fas
antibody (Jo2), known to induce massive hepatic apoptosis.16
Liver mitochondria were purified on percoll gradient and
analyzed using western blotting (Figure 5b). The effective-
ness of purification was attested by the presence Cox IV in the
isolated mitochondria. Monitoring of caspase-3 activation in
whole-liver extract confirmed the apoptosis-inducing action of
Jo2. Full-length Met was present in the whole-liver extract,
where its level decreased upon Jo2 treatment; however, it was
never detected in the purified mitochondria. By contrast, a
40-kDa band was detected with the anti-Met antibody both in
whole-liver extracts and purified mitochondria under apoptotic
conditions. Detection of a similar 40-kDa band with the anti-
p40 Met antibody confirms that it corresponds to the pro-
apoptotic fragment. A fragment of similar size was observed in
apoptotic MCF-10A (Figure 5b). Thus, p40 Met is generated
in vivo in the apoptotic mouse liver and localizes pre-
dominantly to the mitochondria.
Mitochondrial localization of p40 Met was further confirmed
with immunofluorescence detection. P40 Met WT (Figure 5d)
and p40 Met K1108A (Supplementary Figure S6) displayed
punctuated intracytoplasmic staining, the latter colocalizing
partially with elongated shape of themitochondria inMCF-10A
cells. In order to define region involved in mitochondrial
localization, we performed an N-terminal deletion of p40 Met
until the I1180 (Figure 5c). Interestingly, this fragment
Figure 2 Consequence of p40 Met expression during the apoptotic response. (a–d) p40 Met Tet-on-inducible MDCK epithelial cells (clone a) and wild-type MDCK cells
were starved, stimulated or not overnight (16 h) with 200 ng/ml doxycycline (Doxy) and treated for 4 h with 30 ng/ml TNFa and 10mg/ml cycloheximide (CHX). (a) Pictures of
Tet-On p40 Met MDCK epithelial cells (clone a). (b) Relative caspase activity was determined from the same amount of proteins (n¼ 3;±S.D.; Student’s test * 0.02). (c) Cells
were stained with trypan blue and the percentage of dead cells was determined (n¼ 3,± S.D.; Student’s test * 0.04). (d) Proteins were resolved using 12% SDS-PAGE and
analyzed using western blotting with an anti-mouse Met antibody, an anti-PARP antibody, an anti-cleaved caspase-3 antibody and an anti-ERK2 antibody to assess loading
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Figure 3 p40 Met phosphorylation and kinase activity. (a) MCF-10A epithelial cells were starved overnight and treated 4 h with 1 mM staurosporin (Stauro) or 15 min with
30 ng/ml HGF/SF. Proteins were immunoprecipitated with antibody against the kinase domain of Met or against p40 Met and analyzed using western blotting with antibody
against the kinase domain of Met or against the phosphorylated tyrosine residues of the Met kinase domain. (b) MDCK epithelial cells were transfected with a vector
expressing the fusion protein TPR-Met or kinase-dead TPR-Met (mutation K1108A). WT or kinase-dead (K1108A) p40 Met Tet-on MDCK epithelial cells were starved and
stimulated or not overnight with 200 ng/ml doxycycline. Proteins were immunoprecipitated with anti-mouse Met antibody or anti-human Met antibody. Immunoprecipitated
proteins were resolved using 12% SDS-PAGE and analyzed using western blotting with an antibody against the kinase domain of Met or against the phosphorylated tyrosine
residues of the Met kinase domain. (c) MDCK epithelial cells were transiently transfected with a vector expressing Flag-tagged wild-type or kinase-dead (K1108A) p40 Met and
treated or not with 0.1mM PHA-665752. Twenty-four hours after transfection, the nuclei were stained with Hoechst, p40 Met was specifically labeled with an anti-flag antibody
and an anti-cleaved caspase-3 antibody was used to detect apoptotic cells. The percentage of caspase-3-positive cells among the Met-expressing cells was determined.
At least 200 cells were counted per well (n¼ 3;±S.D.). (d) Lung cancer cell line EBC-1 was treated 24 h with 0.1mM PHA-665752. Proteins were resolved using 10%
SDS-PAGE and analyzed using western blotting with an antibody against the kinase domain of Met, an antibody against the phosphorylated tyrosine residues of the
Met kinase domain, an anti-cleaved caspase-3 antibody and an anti-GAPDH antibody to assess loading
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displayed an exclusive mitochondrial localization accompa-
nied with a mitochondrial fragmentation (Figure 5 d),
suggesting that the C-terminal region could target p40 Met
to the mitochondria, whereas the N-terminal region could be
involved in other subcellular localization. However, this
construct did not induce cytochrome-c release (data not
shown). Quantification of colocalization using GFP transfec-
tion and cytochrome-c staining as negative and positive
control, respectively (Supplementary Figure S6), confirmed
the partial localization of p40 Met with the mitochondria
(Figure 5 e).
p40 Met induces mitochondrial permeabilization. As
K1108A mutation abrogates both kinase activity and apop-
tosis induced by p40 Met, we searched to identify mutations
disrupting apoptotic response without affecting the kinase
activity. A p40 Met mutated on amino-acid L1110
and D1115 located near the K1108 (p40 Met LD) did not
induce caspase-3 activation (Figure 6a) but still displayed
tyrosine phosphorylation upon transient transfection
(Figure 6b). As expected, caspase inhibitor inhibited p40
Met-induced caspase-3 activation. This demonstrates
further that kinase activity is not involved in the p40
Met-induced apoptosis.
We next evaluated whether p40 Met expression induces
mitochondrial permeabilization a crucial step of apoptosis.
The fragment was found to induce cytochrome-c release in
about 15% of the MCF-10A-transfected cells (Figure 6c),
whereas permeabilization induced by p40Met LD fell to 5%. In
p40 Met-transfected cells, treatment with zVAD did not
prevent cytochrome-c release or nuclear condensation but
on the contrary increased these phenomena. This increase
Figure 4 Effect of p40 Met localization on its apoptotic action. (a) MDCK epithelial cells were transfected with a vector expressing Flag-tagged wild-type p40 Met (p40 Met)
or p40 Met fused to the Src myristoylation site (SMS-p40 Met). Twenty-four hours after transfection, the nuclei were stained with Hoechst (blue staining) and
immunofluorescence staining was performed with an anti-mouse Met antibody (green staining) and an anti-cleaved caspase-3 antibody (red staining). Cells were observed
using fluorescence microscopy. White arrows indicate representative transfected cells expressing p40 Met. (b) The percentage of caspase-3-positive cells among the
Met-expressing cells was determined. At least 200 cells were counted per well (n¼ 3;±S.D.). (c) HEK 293 cells were transfected or not with an empty vector or a vector
expressing Flag-tagged wild-type p40 Met (p40 Met) or SMS-p40 Met. Cell extracts were resolved using 12% SDS-PAGE and analyzed using western blotting with an
anti-mouse Met antibody to assess expression from the transfected vector
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could be the consequence of an inhibition of the late stage of
apoptosis controlled by caspases, which could increase the
detection of mitochondrial release. In favor of this, the number
of p40 Met-positive cells increased under the zVAD treatment
(data not shown). The mitochondrial permeabilization
induced by the fragment thus occurs independently of
caspase activation. Similarly, p40 Met induced Bax activation
monitored with the help of immunofluorescence using the anti-
Bax antibody 6A7, recognizing its active conformation.17 P40
Met-induced Bax activation was also increased upon caspase
inhibition (Figure 6d). This suggests that p40 Met may act at
an early step of apoptosis to induce release from the
mitochondria and that the caspase inhibitor might prevent
later events in apoptosis.
Figure 5 p40 Met localizes partially to the mitochondria. (a) MCF-10A epithelial cells were starved overnight and treated for 4 h with 1mM staurosporin (Stauro). After
treatment, the cells were fractionated into a nuclear, a cytosolic and a mitochondrial fraction. The same amount of proteins from the whole-cell lysates and the different
fractions was resolved using 12% SDS-PAGE and analyzed using western blotting with antibodies against p40 Met, the nuclear protein Nup 62, the cytosolic protein GAPDH or
the inner mitochondrial membrane protein Cox IV. (b) Mice were injected with saline (ø) or Jo2 antibody at the indicated time. After treatment, their livers were removed and the
mitochondria were isolated. The same amount of proteins from the liver and the purified mitochondria was resolved using 15 or 10% SDS-PAGE and analyzed using western
blotting with antibodies against p40 Met, the kinase domain of Met, the cytosolic protein GAPDH or the inner mitochondrial membrane protein Cox IV. The same amount of
MCF-10A whole-cell lysate, treated or not for 4 h with 1 mM anisomycin, was used as a control for p40 Met detection. Arrows indicate p40 Met and a nonspecific band (NS).
(c) Schematic representation of p40 Met N-terminally deleted versions. (d,e) MCF-10A epithelial cells were transfected with a vector expressing Flag-tagged wild-type p40 Met
(p40 Met), kinase-dead p40 Met (p40 Met K1108A) or a Flag-tagged N-terminally deleted version until isoleucine 1128 (DI1128 p40 Met), as indicated. Twenty-four hours after
transfection, the nuclei were stained with Hoechst (blue staining), the mitochondria were stained with MitoTracker (Red), and immunofluorescence staining was performed with
an anti-Flag antibody (green staining). (d) The cells were observed using fluorescence confocal microscopy. (e) Weighted colocalization coefficients of GFP, p40 Met, p40 Met
K1108A, DI1128 p40 Met and Cytochrome-c staining (green) with Mitotracker staining (Red) were measured from the fluorescence confocal microscopy images (n¼ 4;±S.D.)
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To assess the involvement of Bcl-2 regulators, we co-
expressed the Met fragment with either the anti-apoptotic
Bcl-2 and Bcl-xL or with siRNA targeting Bak and Bax. P40
Met-induced cytochrome-c release was efficiently inhibited by
Bcl-xL co-expression, whereas Bcl-2 did not decrease it
(Figures 7a and b). Efficient and selective silencing of Bak and
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Bax were assessed using quantitative RT-PCR and western
blot (Figures 7c and d). P40 Met-induced cytochrome-c
release was inhibited by the silencing of Bak (Figure 7e),
notably after 72 h displaying optimal Bak silencing
(Figure 7d), whereas silencing of Bax had no effect.
This suggests that Met fragment-induced mitochondrial
permeabilization is dependent on Bak pores negatively
regulated by Bcl-xL.
The Met receptor is involved in both ligand-dependent
survival and mitochondrial permeabilization. To evaluate
the involvement of Met in the mitochondrial permeabilization,
synthesis of the receptor was prevented with siRNA,
and apoptosis was induced with staurosporin. Under control
conditions, induction of apoptosis led to p40 Met generation
(Figure 8a), to cytochrome-c release and to condensation
and fragmentation of chromatin (pyknotic nucleus) in about
half of the cells after a 3-h treatment (Figures 8b–d). In
keeping with its survival response, HGF/SF prevented p40
Met generation (Figure 8a) and decreased cytochrome-c
release and the number of pyknotic nucleus (Figures 8b and c).
The siRNAs against c-met inhibited the synthesis of both
the full-length receptor and the p40 Met (Figure 8a). Under
these conditions, cytochrome-c release and the pyknotic
nucleus were again reduced (Figures 8b–d). Hence, Met is
indeed required for efficient mitochondrial release. As
expected in the absence of its receptor, HGF/SF failed to
prevent cytochrome-c release upon Met silencing
(Figure 8b). Thus, under stress and in agreement with the
dependence paradigm, the Met receptor is required for
ligand-triggered cell survival but also participates, in the
absence of ligand and via p40 Met fragment, in mitochondrial
permeabilization.
Discussion
Although p40 Met is generated by caspases, we detected its
expression from 2h after apoptosis induction, at a moment
when caspases are not fully activated. The fragment was
detected with a custom antibody recognizing the sequence
immediately downstream from aspartic acid 1000, confirming
that cleavage occurs at this site. The generation of p40 Met
early in the apoptotic process and its pro-apoptotic action
suggest that it contributes to apoptotic signaling. This
hypothesis was confirmed with p40 Met Tet-on inducible
cells, in which apoptosis is accelerated upon fragment
expression. Altogether, our results suggest that p40 Met is
an amplifier of apoptosis.
In caspase-targeted kinases, cleavage can lead to either
activation or inactivation of kinase and this modulation has a
direct impact on apoptosis.18 For instance, caspase cleavage
of ROCK1 leads to kinase activation, phosphorylation of
myosin light chains and subsequent membrane blebbing,
which is the characteristic of apoptosis.19,20 By contrast,
caspase cleavage abolishes activation of the Akt kinase,
preventing the pro-survival responses.21 We initially demon-
strated that the p40Met includes the entire kinase domain and
that the ATP-binding site mutation is sufficient to abolish its
pro-apoptotic action.10 In addition, we observed that transi-
ently transfected p40 Met displayed phosphorylation,
suggesting thatMet kinase could be involved in its pro-apoptotic
function. However, we demonstrated here that the endo-
genous fragment generated during apoptosis and in Tet-
on-inducible cells displays neither phosphorylation nor kinase
activity. In addition, inhibitors of Met kinase do not affect p40
Met-induced cell death. Hence, Met caspase cleavages do
not generate an active kinase. It is likely that p40 Met
phosphorylation observed exclusively in transient transfec-
tions is the consequence of its massive expression. It is worth
noticing that overexpression of the full-length Met through
transient transfection22 or in cell lines harboring Met gene
amplification14 leads to its constitutive phosphorylation.
Moreover, we have shown that p40 Met displays partial
mitochondrial localization and is able to induce mitochondrial
permeabilization. A pan-caspase inhibitor zVAD does not
inhibit this permeabilization but, in the opposite way,
increase it. Therefore, p40Met controls MOMP independently
of caspase activation, although its own generation requires
caspase cleavages. Deletion of the N-terminal region of p40
Met until I1128 increases its mitochondrial localization,
suggesting that its C-terminal region may be involved in its
mitochondrial localization. Expression of Bcl-xL decreases
p40 Met-induced mitochondrial permeabilization, whereas
Bcl-2 is ineffective. In a complementary experiment, Bak
silencing decreases permeabilization, whereas Bax silencing
was ineffective. Thus, p40 Met-induced MOMP is dependent
on Bak and is negatively regulated by Bcl-xL. Consistently,
Bak interacts preferentially with Bcl-xL and Mcl-1, whereas
Bax interacts preferentially with Bcl-2.23,24 Thus, Bak is
displaced and it induces cell death when cytotoxic signals
activate BH3-only proteins that can engage both Mcl-1 and
Bcl-xL.
The survival response induced by ligand-stimulated Met
notably involves increased expression of the anti-apoptotic
Bcl-xL and Bcl-2 proteins, leading to the inhibition of
mitochondria-dependent apoptosis.7,8 Under ligand stimulation,
Figure 6 Cytochrome-c release induced by p40 Met. (a) MCF-10A epithelial cells were transiently transfected with a vector expressing Flag-tagged wild-type p40 Met (p40
Met), kinase-dead p40 Met (p40 Met K1108A) or mutated on the amio acid L1110 and D1115 (p40 Met LD) and treated or not with 20 mM caspase inhibitor zVAD-FMK.
Twenty-four hours after transfection, the nuclei were stained with Hoechst, and immunofluorescence staining was performed with an anti-mouse Met antibody and an
anti-cleaved caspase-3 antibody. The percentage of activated caspase-3 among the Met-transfected cells was determined. At least 200 cells were counted per well (n¼ 3;
±S.D.). (b) HEK 293 cells were transfected or not with an empty vector or a vector expressing Flag-tagged wild-type p40 Met, p40 Met K1108A or p40 Met LD. Cell extracts
were resolved using 12% SDS-PAGE and analyzed using western blotting with an anti-mouse Met and anti-phospho Met antibodies. (c,d) MCF-10A epithelial cells were
transiently transfected with a vector expressing Flag-tagged wild-type p40 Met or p40 Met LD and treated or not 20mM caspase inhibitor zVAD-FMK. Twenty-four hours after
transfection, the nuclei were detected with Hoechst (blue staining) and immunofluorescence staining was performed with an anti-Flag antibody (red staining) and an anti-
cytochrome-c (c) or an anti-Bax 6A7 antibody (d) (green staining). Cells were observed using fluorescence microscopy. The percentage of Met-transfected cells displaying
cytochrome-c release was determined. At least 200 cells were counted per well (n¼ 3;±S.D.). Representative pictures of transfected cells displaying cytochrome-c release
or Bax 6A7 staining are shown. White arrows indicate transfected cells
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we previously showed that tyrosine phosphorylation of the
residue 1001 of the CBL-binding site prevents caspase
cleavage at the aspartic acid 1000,12 thus inhibiting p40 Met
generation. In the absence of ligand and under stress, by
contrast, p40 Met promotes mitochondria-dependent apoptosis
involving Bak and is negatively regulated by Bcl-xL. Thus,
the Met receptor can affect intrinsic apoptosis in opposite
ways according to the cellular conditions, tipping the survival/
apoptosis balance one way or the other. These opposite
responses were confirmed by silencing Met, inhibiting both
survival induced by HGF/SF and the mitochondrial release in
the absence of ligand.
Figure 7 Effect of Bcl-2 or Bcl-xL expression and Bak or Bax silencing on p40 Met-induced mitochondrial permeabilization. (a, b) MCF-10A epithelial cells were transiently
transfected with a vector expressing HA-tagged wild-type p40 Met and with vectors expressing Flag-tagged Bcl-2 or Bcl-xL and treated with 20 mM caspase inhibitor zVAD-
FMK. (a) Twenty-four hours after transfection, cells were lysed and extracts were resolved using 10% SDS-PAGE and analyzed using western blotting with anti-Flag and anti-
GAPDH antibodies. (b) For immunofluorescence, the nuclei were detected with Hoechst, and immunofluorescence staining was performed with an anti-HA antibody and an
anti-cytochrome-c antibody. Cells were observed using fluorescence microscopy. The percentage of p40 Met-transfected cells displaying cytochrome-c release was
determined. At least 200 cells were counted per well (n¼ 3;±S.D.). Representative picture of transfected cells displaying or not cytochrome-c release is shown. White arrows
indicate transfected cells. (c–e) MCF-10A epithelial cells were transfected with siRNA control or targeting Bak or Bax. The next day (48 h) or 2 days later (72 h), the cells were
transfected by Flag-tagged wild-type p40 Met. Twenty-four hours after p40 Met transfection, the cells were lysed and extracts were analyzed using quantitative RT-PCR for
expression of Bak and Bax mRNA (n¼ 5;±S.D. in two independent experiments) (c) or using western blotting with an anti-Bak and an anti-Bax antibody. Similar extracts
were then analyzed with an anti-GAPDH antibody (d). For immunofluorescence, the nuclei were detected with Hoechst, and immunofluorescence staining was performed with
an anti-Flag antibody and an anti-cytochrome-c antibody. Cells were observed using fluorescence microscopy. The percentage of Met-transfected cells displaying cytochrome-c
release was determined. At least 200 cells were counted per well (n¼ 3;±S.D.) (e)
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We have previously shown that generation of the
pro-apoptotic fragment p40 Met required initial cleavages by
caspase-3. In addition, in contrast to other dependence
receptors such as DCC and UNC5H, ectopic expression of
full-length Met does not lead by its own to apoptotic cell
death.11 Tet-on-inducible cells revealed now that the fragment
is able to accelerate cell death only when cells are engaged in
the apoptotic process. Therefore, the action of Met as
dependence receptor seems conditioned by an original stress
sufficient to initiate apoptosis.
The apoptotic responses induced by several dependence
receptors have recently been elucidated. For instance, upon
ligand withdrawal, DCC is cleaved by a first round of local
caspase activation, which leads to the exposure of an
addiction or dependence domain (ADD). The receptor then
associates indirectly with caspase-9, leading to further
caspase activation.25,26 In the case of Patched, ligand
withdrawal initiates its caspase cleavage, allowing recruit-
ments of DRAL, TUCAN and caspase-9. These mechanisms
are reminiscent of those triggered by death receptors such as
FAS which, by recruiting the death-inducing signaling com-
plex (DISC), control caspase-8 activation.27 This has led to
the view that Patched and DCC dependence receptors trigger
extrinsic apoptosis. We demonstrate here that upon Met
cleavage, the p40 Met promote mitochondrial permeabilization,
which amplifies apoptotic cell death. The Met-dependence
receptor thus triggers apoptosis via the intrinsic pathway.
Interestingly, it is the membrane-anchored fragments of DCC
andPatched that induce apoptosis, whereas the pro-apoptotic
p40Met fragment is no longer linked to themembrane and can
localize to themitochondria. This suggests that the subcellular
localization of the ADD-containing fragment may determine
the apoptotic pathway. For RTKs such as Ret and TRKC, the
ADD domain is in the cytoplasmic fragment, whereas for Alk
and EphA4, it remains anchored to the membrane.13 This
suggests that these RTKs may cause dependence through
distinct mechanisms.
In transformed cells, the survival/apoptosis balance is often
deregulated in favor of survival. The Met receptor may
contribute to this imbalance through its aberrant activation,
leading to survival.3 Many strategies are developed to prevent
Met activation, such as the use of ATPmimetics targeting Met
kinase or silencing of Met expression.28 We show here that, in
lung cancer cell lines EBC-1 exhibiting Met-addiction, treat-
ment with Met kinase inhibitor was sufficient to induce
caspase-3 activation accompanied with the generation of
the p40 Met fragment. Interestingly, Met kinase inhibitors
efficiently prevent Met-dependent survival without affecting
Figure 8 Consequence of Met silencing on mitochondrial release. (a–d) MCF-10A epithelial cells were transfected with a control siRNA or a pool of three Met-targeting
siRNAs for 24 h and starved overnight. Then the cells were treated for 2 h with HGF/SF (30 ng/ml) before staurosporin (1mM) treatment at the indicated time. (a) Cells were
lysed, proteins were resolved using 10% SDS-PAGE and analyzed using western blotting with antibodies against the kinase domain of Met and against ERK2. (b–d) For each
condition, the nuclei were stained with Hoechst (blue staining), and immunofluorescence was performed with an anti-cytochrome-c antibody (green staining). Cells were
observed using fluorescence microscopy. (b,c) The percentage of cells displaying cytochrome-c release and condensed chromatin (pyknotic nucleus) were determined (200
cells were counted per well; n¼ 3;±S.D.)
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p40 Met-induced apoptosis. By contrast, silencing of Met
expression with siRNA inhibits both ligand-dependent survival
and p40 Met-dependent mitochondrial release. Our findings
thus reveal that Met kinase inhibitors offer the advantage of
preserving the pro-apoptotic action of Met, which could further
participate in causing the death of treated transformed cells.
Materials and Methods
Cytokines, drugs and cell cultures. Human recombinant HGF/SF and
TNFa were purchased from Peprotech (Rocky Hill, NJ, USA). The Met kinase
inhibitors PHA-665752 and SU-11274 were purchased from Promega (Madison,
WI, USA) and Biomol Research Laboratories (Philadelphia, PA, USA),
respectively. Anisomycin and the caspase inhibitor zVAD-FMK were purchased
from Calbiochem (San Diego, CA, USA). Staurosporin, doxycycline and
cyclosporin A were purchased from Sigma (St Louis, MO, USA). Cycloheximide
was purchased from ICN (Irvine, CA, USA).
HEK 293, Madin–Darby canine kidney (MDCK) epithelial cells and p40 Met
Tet-on inducible MDCK epithelial cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum (FBS, Invitrogen) or fetal bovine serum tetracycline free (Clontech,
Mountain View, CA, USA) and 1% antibiotics (penicillin 10 000 U/ml – Streptomycin
10 000mg/ml, Invitrogen). MCF-10A spontaneously immortalized human mammary
epithelial cells were cultured in DMEM and HAM’s F12 vol/vol (Invitrogen)
supplemented with 5% horse serum (Invitrogen), 500 ng/ml hydrocortisone
(Calbiochem), 20 ng/ml epidermal growth factor (Peprotech), 10 mg/ml insulin
(Sigma), and 100 ng/ml cholera toxin (Calbiochem) and 1% antibiotics. Cells were
cultured at 37 1C in a water-saturated 5% CO2 atmosphere. Non-small cell lung
cancer cell line EBC-1 was cultured in EMEM (Invitrogen) supplemented with 10%
FBS and 1% antibiotics.
Antibodies. Mouse monoclonal antibody against the C-terminal domain of
mouse Met (B-2) and antibody against Bax (6A7), goat polyclonal antibody against
the C-terminal domain of human actin (C-11), rabbit polyclonal against the
C-terminal domain of human PARP-1 (H250), antibody against ERK2 (C14) and
antibody against Bak (G23) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Mouse monoclonal antibody against the kinase domain of
Met (3D4), Green-fluorescent Alexa fluor 488-conjugated anti-mouse IgG (Hþ L)
and red-fluorescent Alexa fluor 594-conjugated anti-rabbit IgG (Hþ L) were
purchased from Invitrogen. Mouse antibody against cytochrome-c oxidase subunit
4 (20E8) and nucleoporin p62 were purchased from Abcam (Cambridge, MA,
USA). Rabbit polyclonal antibody against activated caspase-3 (Asp 275, no. 9661)
and against the phosphorylated tyrosine (Y 1234/1235) of the Met kinase domain
(no. 3126) were purchased from Cell Signaling Technology (Danvers, MA, USA).
Rabbit polyclonal antibodies against the Flag and HA epitopes were purchased
from Sigma. Custom polyclonal antibody against p40 Met was produced by
Covalab (Villeurbanne, France). Briefly, rabbits were first injected twice with
bridging peptide (NH2-NESVDYRATFPC-COOH, corresponding to the uncleaved
sequence of Met) coupled to keyhole limpet hemocyanin without adjuvant.
Secondly, rabbits were injected twice with neo-peptide NH2-YRATFPC-COOH,
corresponding to the neo-epitope generated by caspase cleavage,10 coupled to
ovalbumin with Freund’s incomplete adjuvant. The antibodies were immunoaffinity-
purified first by passage of the sera through a bridging peptide sepharose column
and then by passage of the flow-through through the Met neo-peptide sepharose
column. The Jo2 antibody (Purified NA/LE) against mouse CD95 (the Fas
receptor) was purchased from BD Pharmingen (San Diego, CA, USA).
Peroxidase-conjugated antibodies against rabbit and mouse IgGs were purchased
from Jackson Immunoresearch Labs (West Grove, PA, USA).
Plasmid constructs. The pSTAR vectors encoding wild-type and K1108A
p40 Met were constructed as follows. Mouse Met fragments (wild-type and
K1108A) were amplified using PCR with the following primers 50-CAGAATT
CATGTACAGAGCTACTTTTCCAG-30 containing the EcoRI restriction site and
50-GTGGATCCTCAATCAATGTTGTCTTGGGATG-30 containing the BamHI
restriction site. The PCR products were inserted into pSTAR29 between the
EcoRI and BamHI restriction sites.
The N-terminally deleted p40 Met I1128 was generated with mouse Met
sequence amplified using PCR with the following forward primers: 50-CTGACT
GAGGGATCCATCATG-30 containing the BamHI restriction site and the reverse
primer 50-GGGCCCTCTAGACCCCTAGCCATC-30 containing an XbaI restriction
site and inserted into pcDNA3 flag between the BamHI and XbaI restriction sites.
The pCMV plasmid constructs encoding HA-tagged wild-type and kinase-dead
p40 Met were made as follows. Mouse Met fragments (wild-type and K1108A) were
amplified using PCR with the following primers 50-CCCGAATTCAATACAGAGC
TACTTTTCCAGAA-30 containing an EcoRI restriction site and 50-GTACCTC
GAGCCCCTCTCAATCAATGTTGTCTTGGG-30. The PCR product was inserted
into pCMV-Ha from Clontech.
The p40 Met fragment mutated at L1110E and D1115E was created with the
QuickChange site-directed mutagenesis system of Stratagene, using pcDNA3 Flag
p40 Met WT as a template and the following primers:
50-GTGCTGTGAAATCCGAGAATAGAATCACAG-30 and 50-CTGTGATTCTA
TTCTCGGATTTGACAGCAC-30 or 50-GAATAGAATCACAGAGATAGAAGAGGT
CTC-30 and 50-GAGACCTCTTCTATCTCTGTGATTCTATTC-30. The amplified
sequences were subcloned into pcDNA3 Flag between the BamHI and XhoI
restriction sites and the presence of the mutation was confirmed using sequencing.
SMS-p40 Met was constructed as follows. The mouse Met fragment was
amplified using PCR with the following primers: 50-CTGGCGGCCGCCTACA
GAGCTACTTTTCCAGAAGACCAG-30 containing a NotI restriction site and
50-TACCTCTAGATCAATCAATGTTGTCTTGGGATGGCAAC-30 containing an
XbaI restriction site. The PCR product was subcloned into pcDNA3-SMS between
the NotI and XbaI restriction sites. Plasmid pcDNA3-SMS was constructed as
follows. A vector containing v-src was amplified using PCR with the following
primers 50-GAATTAATTGCGGCCGCATTGAAAGCGTTAAC-30 containing a NotI
restriction site and 50GACGTGAAGCTTACCACCATGGGGAG-30 containing a
HindIII restriction site. The PCR product was subcloned into an empty pcDNA3
vector between the HindIII and NotI restriction sites. Flag-tagged Bcl-2 and BcL-xL
expressing vectors were generously provided by Gabriel Nunez (University of
Michigan Medical School, Ann Arbor, MI, USA).
Transfections. Transfections of HEK 293 and MDCK cells with polyethyle-
neamine (PEI) Exgen 500 (Euromedex) and Lipofectamine (Invitrogen) reagents
were performed as previously described.11 MCF-10A cells were plated on glass
coverslips in 12-well plates (100 000 per well). The next day, the cells were
transfected with Jet Prime (Polyplus Transfection, Illkirch, France; 0.75mg
DNA/1.2ml Jet Prime reagent/75 ml Jet Prime buffer in 2 ml complete medium).
After 4 h, the transfection medium was replaced by complete medium.
RNA interference. For Met silencing, MCF-10A cells were harvested. A total
of 200 000 cells were incubated with 3ml Lipofectamine 2000 (Invitrogen) mixed
with 3 nM of a pool of three stealth siRNAs (Invitrogen) targeting Met
(50-CCAUUUCAACUGAGUUUGCUGUUAA-30, 50-UCCAGAAGAUCAGUUUCCU
AAUUCA-30, 50CCGAGGGAAUCAUCAUGAAAGAUUU-30). The cells were then
plated in a six-well plate in complete medium. For Bak and Bax silencing,
MCF-10A were plated on glass coverslips in 12-well plates (100 000per well).
The next day, cells were incubated with 4 ml Jet Prime mixed with 40 nM siRNA
targeting Bak (50-GAGAAUGCCUAUGAGUACUUCACCA-30) or Bax (50-CCCAC
CAGCUCUGAGCAGAUCAUGA-30). The next day or 2 days later, the cells were
transfected with vectors expressing p40 Met.
Real-time RT-PCR. Total RNA was extracted from the cells using the
Nucleospin RNA/Protein Kit (Macherey-Nagel) according to the manufacturer’s
protocol. cDNA was reverse-transcribed from the total RNA with random hexamers
using the High Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems,
Life Technologies, Green Island, NY, USA) according to the manufacturer’s
protocol. The mRNA expression of Bak and Bax were evaluated by real-time
RT-PCR using Fast SYBR Green mix (Applied Biosystems) in an MX3005P
instrument (Stratagene, La Jolla, CA, USA). The relative expression was
calculated using the 2(- Delta Delta CT) method. The mRNA levels of each target
gene were normalized to the levels of the housekeeping beta-2-microglobulin
(B2M) gene and represented as fold induction. The primer sequences were as
follows: Bak (Forward, 50-AAATGGCTTCGGGGCAAGGC-30; Reverse, 50-CC
TCCTCTGTGTCCTGGGCTAC-30); Bax (Forward, 50-TGGGCTGGACATTGGA
CTTCCTC-30; Reverse, 50-ACTCCCGCCACAAAGATGGTCAC-30) and B2M
(Forward, 50-GCTGGCGGGCATTCCTGAAG-30; Reverse, 50-TGCTGGATGACGT
GAGTAAACCTG-30).
Western blotting and immunoprecipitation. Western blotting was
performed as previously described.11,30 For immunoprecipitation in MCF-10A, cells
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were cultured 24 h in serum-free medium. The next day, the cells were treated or
not with staurosporin and lysed in PY buffer (50 mM NaCl, 5 mM EDTA, 1% Triton
X-100, 20 mM Tris-HCL pH 7.4).
Immunofluorescence staining. After transfection, the cells were washed
and fixed in 4% PFA at room temperature. The cells were washed and
permeabilized with PBS containing 0.5% Triton X-100 for 10 min at room
temperature and blocked in 0.2% casein for 30 min. Primary antibodies were
incubated for 1 h at room temperature. Combinations of antibodies were used
(mouse anti-C-terminal domain of mouse Met (0.4mg/ml) with rabbit anti-cleaved
caspase-3 (1 : 250); mouse anti-cytochrome-c (5mg/ml) with rabbit anti-Flag
(1mg/ml) or rabbit anti-HA (1/5000)). The cells were washed with PBS and
incubated for 60 min with a combination of Alexa Fluor-conjugated secondary
antibodies (green-fluorescent Alexa Fluor 488-conjugated anti-mouse IgG (Hþ L)
and red-fluorescent Alexa Fluor 594-conjugated anti-rabbit IgG (Hþ L) diluted to
2mg/ml. The cells were washed with PBS and the nuclei counterstained with
Hoechst 33258. Coverslips were mounted with Glycergel mounting medium (Dako,
Carpenteria, CA, USA). For fluorescence microscopy, slides were observed in oil
immersion with an Axion Imager Z1 (Carl Zeiss, Oberkochen, Germany),
numerical aperture: ECL-PLAN NEOFLUAR 40 NA 1.3, with a monochrome
Zeiss AxioCam MRm camera and the Axiovision acquisition software (Carl Zeiss).
For confocal fluorescence microscopy, slides were observed in a LSM 710 Laser
Scanning Microscope (Carl Zeiss), numerical aperture PLAN-APOCHROMAT
63 NA 1.4, with the ZEN acquisition software (Carl Zeiss).
Mitochondrial staining was performed 24 h after transfection. Cells were stained
with 100 nM MitoTracker (Invitrogen) for 30 min at 37 1C and coverslips were
immersed in methanol : acetone (1 : 1) at  20 1C for 10 min. Cells were washed,
0.2% casein was added and incubation was carried out for 30 min to block
nonspecific binding. Staining was performed as described above. Weighted
colocalization coefficients were measured from the fluorescence confocal
microscopy images with the ZEN acquisition software M ¼
P
i
Ch1i ;colcP
i
Ch1i ;total
For annexin V staining, 1.106 MDCK cells were cultured on a 100-mm plate and
transfected or not by Lipofectamine reagents as described above. The next day,
cells were harvested and stained according to the Tali Apoptosis Kit instructions
(Invitrogen, Molecular Probes, Life Technologies). Briefly, Cells were incubated with
Annexin V Alexa Fluor 488 and deposed in suspension in slide. Fluorescence was
scanned with the Tali Image-based Cytometer (Invitrogen, Life Technologies).
In vitro kinase assays. Proteins were immunoprecipitated as described
above. Immune complexes were washed four times with ice-cold lysis PY buffer
and once with kinase buffer (20 mM MOPS pH: 7.2, 7.5 mM MgCl2, 25 mM
glycerophosphate, 5 mM EGTA, 1 mM Na3VO4, 1 mM DTT). Each immuno-
precipitate was incubated for 30 min at 30 1C with 20ml kinase reaction buffer
(kinase buffer supplemented with 50 mM ATP and 10mM (10mCi) [g 33P] ATP
(2000Ci/mmol) (Perkin Elmer, San Jose, CA, USA)). Kinase reactions were
stopped by the addition of 10ml Laemmli sample buffer (5 ). The phosphorylated
proteins were resolved using 12% SDS-polyacrylamide gel electrophoresis and
dried, and incorporation of [g-33P] was visualized with autoradiography on
hyperfilm-MP (Amersham, Arlington Heights, IL, USA).
Subcellular fractionation. MCF-10A cells were collected, washed in PBS,
resuspended in buffer (10 mM Tris pH 7.6, 250 mM sucrose, 10 mM KCl,
0.15 mM MgCl2) and lysed using Dounce homogenization. The suspension was
centrifuged at 850 g for 5 min at 4 1C to collect the nuclear fraction. The resulting
supernatant was centrifuged at 20 000 g for 15 min at 4 1C to pellet the mitochondria.
The cytosolic fraction (supernatant) was then obtained by centrifugation at 100 000 g for
1 h at 4 1C, and the cytosolic proteins were precipitated overnight with acetone at
 20 1C. Each fraction was resuspended in PY buffer and the same amount of protein
was solubilized in Laemmli sample buffer.
Isolation of mouse liver mitochondria. Male C57BL/6 mice weighing
19–20 g and fasted overnight were injected intraperitoneally with 4mg anti-Fas
antibody (Jo2antibody) per mouse or saline buffer.31 Mice were killed by cerebral
dislocation and their livers were quickly removed and placed in ice-cold sucrose
medium A (0.3 Mol/l sucrose, 5 mM TES, pH7.2, 1 mM EGTA, 1 mg/ml BSA).32
The livers were minced and homogenized with a Potter–Elvehjem homogenizer
with a loose-fitting pestle. Nuclei and cell debris were removed with centrifugation
at 760 g for 10 min at 4 1C. Then the supernatant was centrifuged at 8700 g for
10 min at 4 1C to obtain the mitochondrial pellet and resuspended in 300ml
medium A. To separate intact from broken mitochondria, the organelles were
layered on Percoll gradients (10 min at 8800 g) consisting of a layer at 18%, a
layer at 30% and a layer at 60% Percoll (w/v) in medium B (0.3 Mol/l saccharose,
10 mM TES, 0.2 mM EGTA, 1 mg/ml BSA, pH 6.9). Then mitochondria-enriched
fractions were collected from the 30%/60% interface and washed (10 min at
6800 g) with medium A and the pellet was resuspended in 500ml medium A.
Protein concentrations were determined using the BCA protein assay
(ThermoFisher Scientific, Rockford, IL, USA).
Caspase activity. Adherent MDCK cells, detached with trypsin, and cells in
suspension, collected after elimination of the medium by centrifugation, were lysed
in PY buffer without protease inhibitor. Fifty microliter aliquots all containing the
same amount of protein were transferred to a 96-well plate and 50 ml assay buffer
(100 mM Hepes, 10% Sucrose, 10 mM DTT, 500mM EDTA) was added. After
30 min of incubation at 37 1C, the caspase substrate DEVD-AFC (Calbiochem)
was added to each well and the fluorescence was monitored every 10 min for 3 h
(excitation¼ 395 nm, emission¼ 510 nm) with a fluorimeter (BMG Labtech
FLUOstar OPTIMA). The slopes of the activity curves were calculated and
expressed with respect to the untreated control.
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